FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States since 2003.

It’s that time of year again: the dreaded cold and flu season is on the horizon. But lurking in the shadows is a more sinister threat: RSV.

We are stronger when we are all protected against respiratory diseases,” said Dr. Tomas Aragon, public health officer for ...

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...

It often mimics the common cold, but RSV can quickly turn into bronchiolitis and pneumonia. “The older you get, the milder ...

The Oregon Health Authority and public health officials said a winter, fall surge of COVID-19 and the flu are likely.

Mary Washington Healthcare with information to protect your family from RSV--including infants and older adults.

The rates of respiratory syncytial virus-associated hospitalizations were three to nine times higher for assisted living residents compared with the rates for community-dwelling older adults in a ...

Topline results were announced from a phase 3 study assessing the immune response following coadministration of Arexvy and Shingrix.

Often dismissed as just another common cold, RSV can be deadly, especially for infants and older people. Hannah and her twin ...

GSK has revised its annual vaccine sales forecast following new guidance on RSV from the CDC. But new evidence offers new ...

By Lauren Pelley, CBC News, RCI Provinces taking different approaches, many Canadians may be paying out of pocket Respiratory syncytial virus, or RSV (new window), isn’t always top of mind during the ...